Beijing Luzhu Biotechnology Co., Ltd.

HK$15.36As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2480Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 3Y CAGR (16.57%)
Div yield —
ROE (20.10%)
Biotechnology
Beta (5Y) (0.66)
PE TTM —
TSR TTM (27.27%)
Mkt cap HK$3.055B
ROIC (8.89%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
25.31%
(36.27%)
Hold 10|12|3|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.21
0.20
0.22
0.23
3.35%
4.13%
8.79%
19.14%
Revenue¥M
170.2
172.1
168.6
166.4
8.76%
4.95%
3.93%
1.44%
Peers (US$389.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.121
0.166
0.152
EBIT/Intx
1.673
0.335
0.346
Own earn%
(72.05)
(12.50)
(10.45)
Sh yield%
42.72
58.36
59.03
Owners
Insiders/Inst%
5.84
63.98
Short interest%
0.96
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
14–19
$1 testx
0.0
Incr. ROIC%
0